{"gene":"FCGR1A","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":1999,"finding":"The FcγRIa (CD64) ligand-binding α-chain cytoplasmic tail contains autonomous targeting information directing receptor-antigen complexes to MHC class II-containing late endosomes for antigen presentation, independently of the FcR γ-chain ITAM. Radical deletion of the cytoplasmic tail diverted receptor-ligand complexes to the recycling pathway and decreased antigen presentation, demonstrating γ-chain-independent MHC class II presentation by FcγRIa.","method":"Cell transfection with cytoplasmic-tail deletion mutants, immunoelectron microscopy tracking of receptor-antigen complexes, MHC class II antigen presentation assay in IIA1.6 cell model","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with mutagenesis and direct ultrastructural localization, multiple orthogonal methods in one study","pmids":["10397749"],"is_preprint":false},{"year":1999,"finding":"The FcγRIa extracellular domain is sufficient for internalization of infectious dengue virus immune complexes; deletion of the FcγRIa cytoplasmic domain had no effect on receptor-mediated immune complex infectivity, demonstrating that classical ITAM-dependent signaling is not required for this internalization event.","method":"COS cell transfection with native and cytoplasmic-domain-truncated FcγRIa (±γ-chain), plaque assay for dengue virus replication","journal":"Virology","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro reconstitution with truncation mutants, single study","pmids":["10405359"],"is_preprint":false},{"year":1999,"finding":"The cytoplasmic domain (CY) of the FcγRIa α-chain directly alters the functional properties of the FcγRIa/γ-chain receptor complex: deletion of CY slows phagocytosis and endocytosis kinetics, converts calcium-independent phagocytosis to calcium-dependent, and abrogates IL-6 (but not IL-1β) secretion without affecting receptor surface expression.","method":"Stable transfection of full-length vs. CY-deletion mutants of human FcγRIa in mouse macrophage P388D1 cells; phagocytosis, endocytosis kinetics, calcium flux, cytokine secretion assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with mutagenesis, multiple orthogonal functional readouts","pmids":["10514529"],"is_preprint":false},{"year":1998,"finding":"The second and third extracellular domains of FcγRI together confer unique high-affinity monomeric IgG2a binding; domain 1 plays a supporting role in conformational stability. Chimeric receptors replacing domains 1+2 with FcγRII equivalents abolished high-affinity binding; restoring domain 2 of FcγRI (keeping domain 1 of FcγRII) reconstituted high-affinity IgG2a binding.","method":"Generation of chimeric FcγRI/FcγRII receptors by domain exchange, transfection and IgG binding assays","journal":"Molecular immunology","confidence":"High","confidence_rationale":"Tier 1 — domain-swap mutagenesis reconstitution, clear structure-function mapping","pmids":["9881694"],"is_preprint":false},{"year":1996,"finding":"FcγRI cross-linking in IFN-γ-differentiated U937 cells induces tyrosine phosphorylation of Raf-1 (10-fold increase, peaking 1-2 min post-stimulation), recruits Shc-Grb2 complex formation, and precedes activation of the respiratory burst; this signaling is unique to FcγRI and not triggered by FcγRII, FcγRIII, PMA, fMLP, or other stimuli.","method":"FcγRI cross-linking in U937IF cells, immunoprecipitation and western blotting for Raf-1 phosphorylation, Shc-Grb2 co-immunoprecipitation, respiratory burst assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP with kinetics and receptor specificity controls, multiple orthogonal methods","pmids":["8662746"],"is_preprint":false},{"year":1998,"finding":"FcγRI stimulation induces tyrosine phosphorylation of SLP-76, Cbl, and Shc, and promotes formation of a multimolecular SLP-76–Cbl–Shc–Grb2 complex; a phosphorylation-dependent SLP-76–Shc interaction is induced ≥10-fold by FcγRI aggregation, identifying SLP-76 and Cbl as components of FcγRI signal relay.","method":"FcγRI cross-linking in U937IF cells, co-immunoprecipitation, phospho-tyrosine western blotting","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal co-IP with quantitative phosphorylation analysis, single lab","pmids":["9716598"],"is_preprint":false},{"year":2002,"finding":"Serine phosphorylation of the FcγRIa α-chain cytoplasmic domain is a critical regulatory mechanism: truncation or serine-to-alanine mutation of the cytoplasmic domain abolished okadaic-acid-sensitive inhibition of phagocytosis and the early tyrosine phosphorylation cascade, demonstrating that α-chain serine phosphorylation regulates γ-chain ITAM-dependent signaling.","method":"Mutagenesis of cytoplasmic serine residues in human FcγRIa variants expressed in P388D1 macrophages; okadaic acid inhibition experiments; phagocytosis and tyrosine phosphorylation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis with pharmacological validation and multiple functional readouts","pmids":["12200451"],"is_preprint":false},{"year":2002,"finding":"FcγRI−/− mice display impaired endocytosis of monomeric IgG, reduced kinetics of immune complex phagocytosis, defective macrophage ADCC, and impaired immune complex-dependent antigen presentation to primed T cells; FcγRI also controls antibody response magnitude and can function partially without the FcR γ-chain.","method":"FcγRI knockout mouse model, phagocytosis assays, ADCC assays, antigen presentation assays, serum antibody measurements","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — clean KO with multiple defined cellular phenotypes, replicated alongside companion paper","pmids":["11911823"],"is_preprint":false},{"year":2002,"finding":"FcγRI contributes substantially to IgG2a immune complex-induced phagocytosis, cytokine release, cellular cytotoxicity, and antigen presentation in vivo; FcγRI−/− mice show impaired hypersensitivity responses, strongly reduced cartilage destruction in arthritis, and impaired protection from bacterial infection.","method":"FcγR-knockout mouse panel; hypersensitivity models, immune arthritis model, bacterial infection protection assay","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — multiple KO models with defined in vivo phenotypes, strong evidence across multiple assays","pmids":["11911824"],"is_preprint":false},{"year":2004,"finding":"Periplakin C-terminus selectively interacts with the FcγRI α-chain cytoplasmic domain and enhances FcγRI capacity to bind, internalize, and present antigens on MHC class II. TAT peptides disrupting this endogenous FcγRI–periplakin interaction modulate FcγRI ligand binding, establishing periplakin as a novel cytosolic regulator of FcγRI function.","method":"Truncation and alanine-substitution mutagenesis of FcγRI and periplakin; TAT peptide inhibition; erythrocyte-antibody rosetting assay; antigen presentation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis reconstitution plus peptide inhibitor functional validation","pmids":["15161926"],"is_preprint":false},{"year":2004,"finding":"IFN-γ-induced FcγRI (CD64) expression on human mast cells enables their activation by aggregated IgG1 (but not IgG2/3/4), leading to degranulation (β-hexosaminidase release), PGD2, LTC4, IL-3, IL-13, GM-CSF, and TNFα production; C3a produces additive degranulation. Blocking FcγRI with F(ab')2 reduces IgG1-mediated degranulation by 38%.","method":"IFN-γ priming of human mast cells, aggregated IgG stimulation, β-hexosaminidase release assay, receptor-blocking antibody experiments, eicosanoid and cytokine measurements","journal":"Clinical immunology","confidence":"Medium","confidence_rationale":"Tier 2 — receptor-blocking plus multiple functional readouts, single lab","pmids":["15003814"],"is_preprint":false},{"year":2006,"finding":"FcγRIa ITAM signaling (via γ-chain) is required for both phagocytosis and dengue virus immune complex infectivity enhancement; abrogating FcγRIa signaling competency (by expression without γ-chain or with ITAM tyrosine mutant γ-chain) impairs both phagocytosis and dengue IC infectivity, whereas FcγRIIa ITAM abrogation impairs phagocytosis but not infectivity—demonstrating fundamental mechanistic differences between the two receptors.","method":"Site-directed mutagenesis of ITAM tyrosine residues; COS-7 transfection with native/signaling-incompetent receptor variants; plaque assay; flow cytometry for dengue replication","journal":"Journal of virology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis reconstitution with direct functional comparison, multiple receptor variants","pmids":["17005690"],"is_preprint":false},{"year":2007,"finding":"In immature neutrophils, FcγRI (CD64) has a weaker association with the FcR γ-chain than FcαRI does, resulting in absent FcγRI-mediated γ-chain-dependent functions (ADCC, respiratory burst, calcium mobilization, MAPK phosphorylation) while γ-chain-independent internalization proceeds normally via both receptors.","method":"Co-immunoprecipitation of FcγRI and FcαRI with FcR γ-chain in mature vs. immature neutrophils; calcium mobilization, MAPK phosphorylation, ADCC, respiratory burst assays","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal co-IP plus multiple functional readouts, single lab","pmids":["17709506"],"is_preprint":false},{"year":2007,"finding":"Immune complexes inhibit IFN-γ–induced STAT1 phosphorylation through FcγRI: IC-mediated inhibition is reduced in FcR common γ-chain knockout cells, and requires the phosphatase SHP-1 (as shown by motheaten SHP-1 KO cells), suppressing STAT1 without blocking STAT1 binding to the IFN-γ receptor.","method":"Pull-down assays for STAT1 phosphorylation; real-time RT-PCR for IFN-inducible genes; experiments with FcR γ-chain KO and SHP-1 KO (motheaten) mouse cells","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 — epistasis with KO cells, pull-down, multiple readouts; single lab","pmids":["17227821"],"is_preprint":false},{"year":2009,"finding":"LILRB4 (LILRB4) potently inhibits FcγRI (CD64)-mediated TNFα production by dephosphorylating Lck, Syk, LAT, Erk, and c-Cbl (but not α-actinin-4) upon co-ligation with CD64 on monocytes; LILRB4 aggregates to sites of FcγRI activation, and its inhibitory effect is reversed by broad phosphatase inhibitor (pervanadate) but not by the SHP-1-specific inhibitor sodium stibogluconate, implicating phosphatases other than SHP-1.","method":"Co-ligation of LILRB4 and CD64 on THP-1 cells; TNFα ELISA; western blotting for phosphorylated Lck, Syk, LAT, Erk, c-Cbl, α-actinin-4; pharmacological phosphatase inhibition","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple phospho-protein targets identified with pharmacological rescue, multiple orthogonal methods","pmids":["19833736"],"is_preprint":false},{"year":2010,"finding":"FcγRI α-chain cytoplasmic tail interaction with the outer membrane protein A (OmpA) of E. coli K1 enables bacterial entry into macrophages independent of IgG opsonization. OmpA binding to FcγRIa prevents γ-chain recruitment and produces a distinct tyrosine phosphorylation pattern from IgG2a-induced phosphorylation. FcγRIa−/− mice are resistant to E. coli K1 meningitis due to accelerated bacterial clearance and increased CR3 expression.","method":"COS-1 overexpression of full-length vs. C-terminal truncated FcγRIa; FcγRIa−/− mouse bacterial infection model; adoptive macrophage transfer; co-immunoprecipitation; tyrosine phosphorylation analysis","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 — KO mouse with adoptive transfer rescue, cell transfection mutagenesis, co-IP, multiple readouts","pmids":["21124939"],"is_preprint":false},{"year":2010,"finding":"Targeting allergen to FcγRI on dendritic cells upregulates TSLP receptor via a signaling pathway requiring FcγRI-associated src-related tyrosine kinases, Syk, and PI3K; inhibition of TSLP receptor upregulation blocks TSLP-mediated Th2 responses, linking FcγRI signaling to a novel Th2 regulatory pathway.","method":"Monocyte-derived DC priming with FcγRI-targeting allergen fusion protein (H22-Fel d 1); inhibitors of Fc receptor signaling (src kinases, Syk, PI3K); TSLP receptor flow cytometry; T cell cytokine analysis","journal":"The Journal of allergy and clinical immunology","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological pathway dissection with functional T cell readout, single lab","pmids":["20109752"],"is_preprint":false},{"year":2016,"finding":"LILRB4 co-ligation with FcγRI causes Tyr dephosphorylation of key clathrin-mediated endocytosis pathway components—including the FcR common γ-chain, Syk, clathrin, Cbl, HRS, TRIM21, and HSP70—and suppresses FcR-dependent uptake of antibody-opsonized bacterial particles, indicating LILRB4 regulates FcγRI-dependent phagocytosis/endocytosis via Tyr dephosphorylation.","method":"Antibody ligation of FcγRI ± LILRB4 on THP-1 cells; anti-pTyr immunoprecipitation; mass spectrometry peptide sequencing; Ingenuity Pathway Analysis; bacterial phagocytosis assay","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1 — mass spectrometry phosphoproteomics with functional phagocytosis validation, multiple pathway components identified","pmids":["27725776"],"is_preprint":false},{"year":2018,"finding":"Cytokine-induced 'inside-out' signaling enhances FcγRI clustering (nanoscale reorganization) dependent on an intact actin cytoskeleton and on PP1 phosphatase activity (PP1 inhibition reduces inside-out signaling without affecting FcγRI phosphorylation itself); IL-3, TNFα, and IFNγ all stimulate this clustering and enhance ADCC of CD20+ tumor cells by neutrophils.","method":"Super-resolution microscopy (STORM) of FcγRI clustering; pharmacological inhibition of PP1; actin cytoskeleton disruption; ADCC assay with neutrophils","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 1 — super-resolution imaging with pharmacological mechanism dissection and functional ADCC validation","pmids":["30042128"],"is_preprint":false},{"year":2018,"finding":"FcγRI/CD64 promotes immune inflammation via activation of NF-κB signaling, which in turn drives NLRP3 inflammasome formation and IL-1β/IL-18 release; FcγRI expression in Ba/F3 cells induces this pathway, and silencing FcγRI in THP-1 macrophages reverses it.","method":"FcγRI overexpression in Ba/F3 cells; FcγRI siRNA knockdown in THP-1 macrophages; NF-κB inhibitor (PDTC); western blotting for NLRP3 components; ELISA for IL-1β and IL-18","journal":"Life sciences","confidence":"Medium","confidence_rationale":"Tier 2 — gain- and loss-of-function with pharmacological epistasis, single lab","pmids":["29920250"],"is_preprint":false},{"year":2019,"finding":"FcγRI is expressed in a subpopulation of joint sensory neurons; IgG immune complex crosslinking of FcγRI directly activates the somata and peripheral terminals of these neurons to evoke acute joint hypernociception without joint inflammation. Conditional deletion of Fcgr1 in sensory neurons attenuated arthritis pain and joint sensory neuron hyperactivity without altering joint inflammation.","method":"Global and sensory-neuron-specific Fcgr1 conditional knockout mice; ex vivo electrophysiology of joint sensory neurons; behavioral pain assays; inflammatory arthritis models; IgG-IC injection","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific KO with electrophysiology and behavioral readouts, multiple arthritis models","pmids":["31211699"],"is_preprint":false},{"year":2001,"finding":"Exogenous antigen targeted to FcγRI (CD64) on myeloid cells (THP-1) is internalized and processed for presentation on MHC class I molecules, enabling CTL-mediated lysis; blocking either FcγRI or MHC class I abrogates lysis, demonstrating FcγRI-mediated cross-presentation (MHC I) pathway.","method":"FcγRI-targeted PSA fusion protein (FPH22.PSA) on THP-1 cells; CTL cytotoxicity assay; receptor-blocking with anti-FcγRI and anti-MHC class I antibodies","journal":"Journal of immunological methods","confidence":"Medium","confidence_rationale":"Tier 2 — receptor blocking with defined cytolytic readout, single lab","pmids":["11223078"],"is_preprint":false},{"year":2004,"finding":"FcγRI-mediated cross-presentation via MHC class I is enhanced by CpG ODN co-stimulation; hFcγRI transgenic DC show increased MHC class I presentation of FcγRI-targeted antigens (ovalbumin via CD64 mAb fusion) upon CpG addition compared to non-transgenic DC.","method":"hFcγRI transgenic and non-transgenic DC; antigen-CD64 mAb fusion protein targeting; CpG ODN co-stimulation; MHC class I presentation assay with OVA-specific CD8+ T cells","journal":"International immunology","confidence":"Medium","confidence_rationale":"Tier 2 — transgenic model with selective receptor targeting, single lab","pmids":["15192052"],"is_preprint":false},{"year":2004,"finding":"FcγRI (CD64) and FcγRIIB on dendritic cells and macrophages both mediate accelerated antigen presentation (T cell proliferation, IgG production) via immune complex uptake; DC lacking FcγRIIB show reduced IC-uptake and decreased T-cell stimulation, while DC expressing only FcγRIIB (FcR γ-chain deficient) outperform FcγR-null DC, revealing positive regulation of antigen presentation by FcγRIIB alongside FcγRI/III.","method":"FcγRIIB KO and FcR γ-chain KO bone marrow-derived DCs; antigen IC uptake assay; T cell proliferation assay; adoptive DC transfer; serum IgG measurement","journal":"Cellular immunology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple KO models, epistasis-style comparison, single lab","pmids":["14643301"],"is_preprint":false},{"year":1998,"finding":"FcγRIa-γ-chain complexes require an intact γ-chain ITAM to trigger phagocytosis of S. aureus and ADCC of erythrocytes in IIA1.6 cells; both γ-chain ITAM and FcγRIIa ITAM can direct these functions when coupled to the FcγRIa extracellular domain.","method":"FcγRIa-γ-chain complex reconstitution in IIA1.6 cells; ITAM mutant γ-chain; phagocytosis of S. aureus; ADCC assay with erythrocytes","journal":"Clinical and experimental immunology","confidence":"Medium","confidence_rationale":"Tier 2 — receptor reconstitution with ITAM requirement demonstrated, single lab","pmids":["9737671"],"is_preprint":false},{"year":2004,"finding":"FcγRIIA interacts more readily with Syk than does FcγRI/γ-chain chimera, contributing to greater phagocytic efficiency of FcγRIIA; individual Src-related tyrosine kinases (Hck, Lyn) differentially influence phagocytosis efficiency and Syk interaction for FcγRI/γ versus FcγRIIA.","method":"Transfection of FcγRIIA and FcγRI-gamma-gamma chimera in COS-1 cells; co-immunoprecipitation with Syk, Hck, Lyn; phagocytosis assay","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal co-IP with functional phagocytosis comparison, single lab","pmids":["15136586"],"is_preprint":false},{"year":2023,"finding":"Conditional knockout of Fcgr1 in rat DRG neurons significantly alleviates neuropathic pain after sciatic nerve injury; CRP (elevated in DRG after nerve injury) activates neuronal FcγRI-related signals to evoke pain, and microinjection of naive IgG into DRG suppresses FcγRI activation and alleviates pain, establishing a CRP/FcγRI positive-feedback proinflammatory signaling loop in sensory neurons.","method":"Fcgr1 conditional knockout in rat DRG neurons; CRP microinjection into DRG; naive IgG microinjection; behavioral pain assays; signaling analysis in primary neurons","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 — neuron-specific CKO with behavioral and signaling readouts, single lab","pmids":["36727833"],"is_preprint":false},{"year":2015,"finding":"Crystal/structural studies of human FcγRI in complex with IgG-Fc revealed the molecular basis for high-affinity binding, including a potential receptor-glycan interaction as a contributor to affinity differences among FcγRs.","method":"Structural determination (crystallography) of FcγRI–IgG-Fc complex with review of structural data","journal":"Immunological reviews","confidence":"Medium","confidence_rationale":"Tier 1 — structural study, review-based coverage without full original data details in abstract","pmids":["26497521"],"is_preprint":false},{"year":2012,"finding":"CD64 (FcγRI) modulates the inhibitory activity of infliximab: cells expressing CD64 capture infliximab-TNF complexes via the Fc domain, activating CD64 and producing distinct phospho-tyrosine signals; blocking the Fc portion or using Fab fragments of infliximab improves its TNF-neutralizing efficacy. IFN-γ-induced CD64 upregulation correlates with loss of infliximab efficacy, and CD64 knockdown (siRNA) or downregulation (PMA) restores it.","method":"siRNA knockdown of CD64 in THP-1 and PBMCs; Fc-blocking antibody fragments; immunoprecipitation; western blotting for phospho-tyrosine; RT-PCR; immunofluorescence","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — siRNA KD plus pharmacological rescue plus receptor blocking with multiple readouts, single lab","pmids":["22937039"],"is_preprint":false},{"year":2022,"finding":"FCGR1A variants affect CD64 functions: promoter SNV rs1848781 alters promoter activity and CD64 expression levels; intronic indel rs587598788 associates with CD64 expression levels; non-synonymous SNV rs1050204 (p.D324N) significantly affects CD64-mediated phagocytosis, degranulation, and pro-inflammatory cytokine production.","method":"Promoter reporter assay; genotype-phenotype analysis; phagocytosis assay; degranulation assay; cytokine measurement in cells with different FCGR1A genotypes","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 1–2 — promoter reporter + functional assays for coding variant, single lab","pmids":["35371020"],"is_preprint":false},{"year":2025,"finding":"Guselkumab (but not risankizumab) binds CD64 on IFNγ-primed monocytes via its Fc domain, enabling simultaneous capture of IL-23 secreted from CD64+ IL-23-producing inflammatory monocytes; this Fc/CD64-dependent mechanism mediates IL-23 internalization into low-pH compartments and enhances potency of IL-23 neutralization in a CD64+ cell co-culture system.","method":"Flow cytometry binding assays; live-cell confocal imaging of IL-23 internalization; co-culture of CD64+ THP-1 IL-23-producing cells with IL-23-responsive reporter cells; Fc-mutant antibody comparison","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 — imaging with functional co-culture reporter assay and Fc-mutant comparison, single lab","pmids":["40145093"],"is_preprint":false}],"current_model":"FcγRI (CD64; FCGR1A) is a three-extracellular-domain high-affinity IgG receptor whose ligand-binding α-chain forms a functional complex with the ITAM-bearing FcR γ-chain; the α-chain cytoplasmic tail undergoes serine phosphorylation that tonically regulates γ-chain ITAM-dependent signaling, phagocytosis kinetics, IL-6 secretion, and intracellular routing of receptor–antigen complexes to MHC class II late endosomes for antigen presentation, while also enabling γ-chain-independent MHC class II and MHC class I cross-presentation. Upon immune complex ligation, FcγRI activates a Syk/Lck/LAT/SLP-76/Shc/Grb2/Raf-1/ERK signaling cascade to drive phagocytosis, cytokine production (including via NF-κB/NLRP3), ADCC, and respiratory burst; cytokine-driven 'inside-out' signaling reorganizes FcγRI into nanoclusters via an actin- and PP1-phosphatase-dependent mechanism to enhance these effector functions. FcγRI is inhibited by LILRB4 co-ligation through broad Tyr dephosphorylation of Syk, Lck, LAT, Erk, and Cbl, and by immune complex-activated SHP-1, which suppresses STAT1 phosphorylation to dampen IFN-γ signaling. Beyond classical myeloid functions, FcγRI is expressed on joint sensory neurons where IgG immune complex crosslinking directly activates nociceptors to drive arthritis pain independently of inflammation."},"narrative":{"teleology":[{"year":1996,"claim":"Identification of the proximal signaling cascade downstream of FcγRI resolved how this receptor specifically activates the respiratory burst: cross-linking induces Raf-1 tyrosine phosphorylation and Shc–Grb2 complex formation with kinetics preceding functional output, a pathway unique among FcγRs.","evidence":"FcγRI cross-linking in IFN-γ-differentiated U937 cells; immunoprecipitation/western blot for Raf-1, Shc, Grb2; respiratory burst assay","pmids":["8662746"],"confidence":"High","gaps":["Upstream kinase(s) directly phosphorylating Raf-1 downstream of FcγRI not identified","No direct link to ERK demonstrated in this study"]},{"year":1998,"claim":"Domain-swap mutagenesis established that the second and third extracellular domains of FcγRI are the structural determinants of high-affinity monomeric IgG binding, distinguishing it from low-affinity FcγRs and explaining its unique ligand-binding properties.","evidence":"Chimeric FcγRI/FcγRII receptors by domain exchange; IgG binding assays in transfected cells","pmids":["9881694"],"confidence":"High","gaps":["Atomic-resolution contacts not defined until later crystallography","Contribution of receptor glycosylation to affinity not tested"]},{"year":1998,"claim":"The requirement for an intact γ-chain ITAM for FcγRI-mediated phagocytosis and ADCC was formally demonstrated, confirming that the γ-chain is the essential signaling subunit and that SLP-76, Cbl, and Shc participate as downstream adaptors.","evidence":"FcγRI reconstitution with wild-type or ITAM-mutant γ-chain in IIA1.6 cells; phagocytosis and ADCC assays; co-IP of SLP-76/Cbl/Shc complex in U937 cells","pmids":["9737671","9716598"],"confidence":"Medium","gaps":["Relative contributions of individual ITAM tyrosines not dissected","No direct kinase–substrate relationships established for SLP-76 or Cbl"]},{"year":1999,"claim":"The α-chain cytoplasmic tail was shown to carry autonomous targeting information directing receptor–antigen complexes to MHC class II late endosomes and to regulate phagocytosis kinetics, calcium dependence, and IL-6 secretion independently of the γ-chain ITAM, establishing a dual-function model for FcγRI signaling.","evidence":"Cytoplasmic tail deletion/truncation mutants in IIA1.6 and P388D1 cells; immunoelectron microscopy; antigen presentation, phagocytosis, calcium flux, and cytokine secretion assays","pmids":["10397749","10514529"],"confidence":"High","gaps":["Specific sorting motifs within the cytoplasmic tail not mapped to individual residues","Mechanism of calcium-independent phagocytosis not elucidated"]},{"year":2001,"claim":"FcγRI was demonstrated to mediate cross-presentation on MHC class I, expanding its antigen-presentation repertoire beyond MHC class II and identifying it as a route for CTL priming by myeloid cells.","evidence":"FcγRI-targeted PSA fusion protein on THP-1 cells; CTL cytotoxicity assay with receptor-blocking antibodies","pmids":["11223078"],"confidence":"Medium","gaps":["Molecular pathway linking FcγRI internalization to MHC class I loading not defined","Contribution of proteasomal vs. vacuolar processing not tested"]},{"year":2002,"claim":"FcγRI knockout mice revealed the in vivo requirement for FcγRI in IgG2a immune complex-mediated phagocytosis, ADCC, antigen presentation, hypersensitivity, cartilage destruction in arthritis, and bacterial defense—establishing that FcγRI is non-redundant with other activating FcγRs in vivo.","evidence":"FcγRI−/− mouse models; phagocytosis, ADCC, antigen presentation assays; arthritis and bacterial infection models","pmids":["11911823","11911824"],"confidence":"High","gaps":["Relative contributions of monocytes vs. macrophages vs. DCs to each phenotype not resolved","Compensatory changes in other FcγRs not fully assessed"]},{"year":2002,"claim":"Serine phosphorylation of the α-chain cytoplasmic domain was identified as a tonic regulatory mechanism governing γ-chain ITAM-dependent signaling: serine-to-alanine mutations abolished okadaic acid-sensitive inhibition of phagocytosis and the early tyrosine phosphorylation cascade.","evidence":"Serine-to-alanine mutagenesis of FcγRI cytoplasmic domain in P388D1 macrophages; okadaic acid treatment; phagocytosis and phospho-tyrosine assays","pmids":["12200451"],"confidence":"High","gaps":["Identity of the serine kinase(s) responsible not determined","Specific serine residues mapped only partially"]},{"year":2004,"claim":"Periplakin was identified as a cytosolic partner of the FcγRI α-chain that enhances ligand binding, internalization, and MHC class II antigen presentation, revealing a novel cytoskeletal-associated regulatory axis for FcγRI.","evidence":"Mutagenesis of FcγRI and periplakin; TAT peptide inhibition of the interaction; rosetting and antigen presentation assays","pmids":["15161926"],"confidence":"High","gaps":["Structural basis of periplakin–FcγRI interaction unknown","Whether periplakin regulates FcγRI on primary cells in vivo not tested"]},{"year":2007,"claim":"Two inhibitory checkpoints on FcγRI signaling were defined: LILRB4 co-ligation broadly dephosphorylates Syk, Lck, LAT, Erk, and Cbl to suppress TNF production, while immune complex-activated SHP-1 suppresses STAT1 phosphorylation to dampen IFN-γ signaling—establishing layered negative regulation of FcγRI effector functions.","evidence":"LILRB4/CD64 co-ligation on THP-1 monocytes with phospho-protein western blots and phosphatase inhibitors; STAT1 phosphorylation in FcR γ-chain KO and SHP-1 KO (motheaten) mouse cells","pmids":["19833736","17227821"],"confidence":"High","gaps":["Identity of the LILRB4-recruited phosphatase(s) other than SHP-1 not established","Whether LILRB4 and SHP-1 pathways converge or operate independently unknown"]},{"year":2010,"claim":"FcγRI was found to serve as a direct entry receptor for E. coli K1 via OmpA binding to the α-chain, independent of IgG opsonization, establishing a pathogen subversion mechanism; FcγRI−/− mice resist E. coli K1 meningitis.","evidence":"COS-1 overexpression of full-length vs. C-terminal truncated FcγRI; FcγRI−/− mouse infection model; adoptive macrophage transfer; co-IP and phospho-tyrosine analysis","pmids":["21124939"],"confidence":"High","gaps":["Precise OmpA binding site on FcγRI α-chain not mapped","Whether other bacteria exploit this pathway not tested"]},{"year":2018,"claim":"Cytokine-induced inside-out signaling was shown to reorganize FcγRI into nanoclusters via an actin- and PP1-phosphatase-dependent mechanism, enhancing ADCC—revealing that FcγRI effector potency is tuned by receptor spatial organization rather than expression level alone.","evidence":"STORM super-resolution imaging of FcγRI clustering on neutrophils; PP1 and actin inhibitors; ADCC assay against CD20+ tumor cells","pmids":["30042128"],"confidence":"High","gaps":["PP1 substrate(s) controlling clustering not identified","Whether nanoclustering affects antigen presentation not tested"]},{"year":2019,"claim":"FcγRI was discovered on joint sensory neurons, where IgG immune complex crosslinking directly activates nociceptors to drive arthritis pain independently of inflammation—extending FcγRI function beyond the immune system to the nervous system.","evidence":"Global and sensory-neuron-specific Fcgr1 conditional KO mice; ex vivo electrophysiology; behavioral pain assays in multiple arthritis models","pmids":["31211699"],"confidence":"High","gaps":["Downstream signaling pathway in neurons not fully characterized","Whether neuronal FcγRI associates with FcR γ-chain or signals independently unknown"]},{"year":2023,"claim":"The neuronal FcγRI pain axis was extended to neuropathic pain: CRP activates neuronal FcγRI after nerve injury via a positive-feedback proinflammatory loop, and naive IgG competing for FcγRI suppresses this activation and alleviates pain.","evidence":"Fcgr1 conditional KO in rat DRG neurons; CRP and naive IgG microinjection into DRG; behavioral pain assays and signaling analysis","pmids":["36727833"],"confidence":"Medium","gaps":["CRP binding site on FcγRI not mapped","Whether CRP/FcγRI signaling uses ITAM-dependent or independent pathway not resolved","Single lab finding, not independently confirmed"]},{"year":null,"claim":"Key unresolved questions include the identity of the serine kinase(s) and PP1 substrates that control α-chain phosphorylation and nanocluster formation, the structural basis for dual γ-chain-dependent and -independent signaling from the same receptor, and the full signaling pathway mediating neuronal FcγRI-driven nociception.","evidence":"","pmids":[],"confidence":"Low","gaps":["No serine kinase identified for α-chain cytoplasmic tail","Structural model of full-length FcγRI in complex with γ-chain lacking","Neuronal FcγRI signaling pathway incompletely defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[3,27]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[6,18]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,18,29]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[0,9]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[0,17]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[4,7,8,14,17,18,24]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,5,6,13,16,19]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[0,17]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[1,11,15]}],"complexes":["FcγRI α-chain / FcR γ-chain signaling complex"],"partners":["FCER1G","SYK","SHC1","GRB2","SLP76","LILRB4","PPL","CBL"],"other_free_text":[]},"mechanistic_narrative":"FCGR1A (CD64/FcγRI) is a high-affinity IgG receptor on myeloid cells that couples immune complex recognition to phagocytosis, antibody-dependent cellular cytotoxicity, antigen presentation, and inflammatory cytokine production. The ligand-binding α-chain, whose second and third extracellular domains confer high-affinity IgG binding [PMID:9881694], associates with the ITAM-bearing FcR γ-chain to activate a Syk/Shc/Grb2/Raf-1/ERK signaling cascade that drives phagocytosis, respiratory burst, and NF-κB/NLRP3-dependent IL-1β release [PMID:8662746, PMID:29920250]; the α-chain cytoplasmic tail independently directs receptor–antigen complexes to MHC class II late endosomes and enables MHC class I cross-presentation, while its serine phosphorylation tonically regulates γ-chain ITAM signaling and phagocytosis kinetics [PMID:10397749, PMID:12200451, PMID:11223078]. Cytokine-driven inside-out signaling reorganizes FcγRI into actin- and PP1-phosphatase-dependent nanoclusters that enhance ADCC [PMID:30042128], whereas inhibitory co-receptors LILRB4 and SHP-1 suppress FcγRI effector functions through broad tyrosine dephosphorylation of downstream signaling components [PMID:19833736, PMID:17227821]. Beyond myeloid cells, FcγRI is expressed on joint sensory neurons where IgG immune complex crosslinking directly activates nociceptors to drive arthritis pain independently of inflammation [PMID:31211699]."},"prefetch_data":{"uniprot":{"accession":"P12314","full_name":"High affinity immunoglobulin gamma Fc receptor I","aliases":["Fc-gamma RI","FcRI","Fc-gamma RIA","FcgammaRIa"],"length_aa":374,"mass_kda":42.6,"function":"High affinity receptor for the Fc region of immunoglobulins gamma. Functions in both innate and adaptive immune responses. Mediates IgG effector functions on monocytes triggering antibody-dependent cellular cytotoxicity (ADCC) of virus-infected cells","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P12314/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/FCGR1A","classification":"Common Essential","n_dependent_lines":316,"n_total_lines":380,"dependency_fraction":0.8315789473684211},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FCGR1A","total_profiled":1310},"omim":[{"mim_id":"615978","title":"IMMUNODEFICIENCY 27B; IMD27B","url":"https://www.omim.org/entry/615978"},{"mim_id":"613562","title":"Fc RECEPTOR-LIKE PROTEIN 6; FCRL6","url":"https://www.omim.org/entry/613562"},{"mim_id":"611775","title":"KAWASAKI DISEASE","url":"https://www.omim.org/entry/611775"},{"mim_id":"606891","title":"Fc RECEPTOR-LIKE PROTEIN A; FCRLA","url":"https://www.omim.org/entry/606891"},{"mim_id":"606510","title":"Fc RECEPTOR-LIKE PROTEIN 3; FCRL3","url":"https://www.omim.org/entry/606510"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Vesicles","reliability":"Uncertain"},{"location":"Golgi apparatus","reliability":"Additional"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"epididymis","ntpm":95.0}],"url":"https://www.proteinatlas.org/search/FCGR1A"},"hgnc":{"alias_symbol":["CD64","CD64A","FcgammaRI","FcgammaRIa","FCG1","FCGR1"],"prev_symbol":[]},"alphafold":{"accession":"P12314","domains":[{"cath_id":"2.60.40.10","chopping":"21-102","consensus_level":"medium","plddt":92.7872,"start":21,"end":102},{"cath_id":"2.60.40.10","chopping":"104-187","consensus_level":"medium","plddt":96.2635,"start":104,"end":187},{"cath_id":"2.60.40.10","chopping":"194-282","consensus_level":"high","plddt":93.2628,"start":194,"end":282}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P12314","model_url":"https://alphafold.ebi.ac.uk/files/AF-P12314-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P12314-F1-predicted_aligned_error_v6.png","plddt_mean":85.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FCGR1A","jax_strain_url":"https://www.jax.org/strain/search?query=FCGR1A"},"sequence":{"accession":"P12314","fasta_url":"https://rest.uniprot.org/uniprotkb/P12314.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P12314/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P12314"}},"corpus_meta":[{"pmid":"11911824","id":"PMC_11911824","title":"FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection.","date":"2002","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11911824","citation_count":223,"is_preprint":false},{"pmid":"18495955","id":"PMC_18495955","title":"Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18495955","citation_count":173,"is_preprint":false},{"pmid":"8752900","id":"PMC_8752900","title":"Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells.","date":"1996","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8752900","citation_count":162,"is_preprint":false},{"pmid":"11911823","id":"PMC_11911823","title":"FcgammaRI-deficient mice show multiple alterations to inflammatory and immune responses.","date":"2002","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11911823","citation_count":155,"is_preprint":false},{"pmid":"20206205","id":"PMC_20206205","title":"Neutrophil CD64 expression as marker of bacterial infection: a systematic review and meta-analysis.","date":"2010","source":"The Journal of infection","url":"https://pubmed.ncbi.nlm.nih.gov/20206205","citation_count":130,"is_preprint":false},{"pmid":"21325219","id":"PMC_21325219","title":"Functional characteristics of the high affinity IgG receptor, FcγRI.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21325219","citation_count":128,"is_preprint":false},{"pmid":"19642859","id":"PMC_19642859","title":"Neutrophil CD64: a diagnostic marker for infection and sepsis.","date":"2009","source":"Clinical chemistry and laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19642859","citation_count":126,"is_preprint":false},{"pmid":"9435876","id":"PMC_9435876","title":"Clinical experience with CD64-directed immunotherapy. An overview.","date":"1997","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/9435876","citation_count":114,"is_preprint":false},{"pmid":"22940278","id":"PMC_22940278","title":"Neutrophil CD64 expression as a biomarker in the early diagnosis of bacterial infection: a meta-analysis.","date":"2012","source":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22940278","citation_count":105,"is_preprint":false},{"pmid":"17005690","id":"PMC_17005690","title":"Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32).","date":"2006","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/17005690","citation_count":103,"is_preprint":false},{"pmid":"15003814","id":"PMC_15003814","title":"Activation of human mast cells by aggregated IgG through FcgammaRI: additive effects of C3a.","date":"2004","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/15003814","citation_count":91,"is_preprint":false},{"pmid":"26059345","id":"PMC_26059345","title":"Neutrophil CD64 expression as a diagnostic marker for sepsis in adult patients: a meta-analysis.","date":"2015","source":"Critical care (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26059345","citation_count":89,"is_preprint":false},{"pmid":"11529918","id":"PMC_11529918","title":"Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with the systemic inflammatory response syndrome (SIRS).","date":"2001","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11529918","citation_count":87,"is_preprint":false},{"pmid":"20478071","id":"PMC_20478071","title":"Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus.","date":"2010","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/20478071","citation_count":78,"is_preprint":false},{"pmid":"8847330","id":"PMC_8847330","title":"Adaptation to eccentric exercise: effect on CD64 and CD11b/CD18 expression.","date":"1996","source":"Journal of applied physiology (Bethesda, Md. : 1985)","url":"https://pubmed.ncbi.nlm.nih.gov/8847330","citation_count":75,"is_preprint":false},{"pmid":"14643301","id":"PMC_14643301","title":"Accelerated antigen presentation and elicitation of humoral response in vivo by FcgammaRIIB- and FcgammaRI/III-mediated immune complex uptake.","date":"2003","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/14643301","citation_count":73,"is_preprint":false},{"pmid":"10397749","id":"PMC_10397749","title":"The FcgammaRIa (CD64) ligand binding chain triggers major histocompatibility complex class II antigen presentation independently of its associated FcR gamma-chain.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10397749","citation_count":72,"is_preprint":false},{"pmid":"11071653","id":"PMC_11071653","title":"Therapeutic efficacy of FcgammaRI/CD64-directed bispecific antibodies in B-cell lymphoma.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11071653","citation_count":59,"is_preprint":false},{"pmid":"18336730","id":"PMC_18336730","title":"Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis.","date":"2008","source":"International journal of immunopathology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18336730","citation_count":55,"is_preprint":false},{"pmid":"30733320","id":"PMC_30733320","title":"The Impact of FcγRI Binding on Immuno-PET.","date":"2019","source":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30733320","citation_count":54,"is_preprint":false},{"pmid":"9881694","id":"PMC_9881694","title":"The second and third extracellular domains of FcgammaRI (CD64) confer the unique high affinity binding of IgG2a.","date":"1998","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9881694","citation_count":52,"is_preprint":false},{"pmid":"17621550","id":"PMC_17621550","title":"Hematological indices, inflammatory markers and neutrophil CD64 expression: comparative trends during experimental human endotoxemia.","date":"2007","source":"Journal of endotoxin research","url":"https://pubmed.ncbi.nlm.nih.gov/17621550","citation_count":52,"is_preprint":false},{"pmid":"31211699","id":"PMC_31211699","title":"Neuronal FcγRI mediates acute and chronic joint pain.","date":"2019","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/31211699","citation_count":51,"is_preprint":false},{"pmid":"26497519","id":"PMC_26497519","title":"The many faces of FcγRI: implications for therapeutic antibody function.","date":"2015","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/26497519","citation_count":48,"is_preprint":false},{"pmid":"20407370","id":"PMC_20407370","title":"The novel applications of the quantitative analysis of neutrophil cell surface FcgammaRI (CD64) to the diagnosis of infectious and inflammatory diseases.","date":"2010","source":"Current opinion in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/20407370","citation_count":44,"is_preprint":false},{"pmid":"11223078","id":"PMC_11223078","title":"Exogenous antigen targeted to FcgammaRI on myeloid cells is presented in association with MHC class I.","date":"2001","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/11223078","citation_count":43,"is_preprint":false},{"pmid":"19833736","id":"PMC_19833736","title":"Leukocyte Ig-like receptor B4 (LILRB4) is a potent inhibitor of FcgammaRI-mediated monocyte activation via dephosphorylation of multiple kinases.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19833736","citation_count":43,"is_preprint":false},{"pmid":"19098857","id":"PMC_19098857","title":"Expression of the high-affinity IgG receptor FcRI (CD64) in patients with inflammatory bowel disease: a new biomarker for gastroenterologic diagnostics.","date":"2009","source":"The American journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/19098857","citation_count":43,"is_preprint":false},{"pmid":"29668526","id":"PMC_29668526","title":"Immunophenotyping of Monocytes During Human Sepsis Shows Impairment in Antigen Presentation: A Shift Toward Nonclassical Differentiation and Upregulation of FCγRi-Receptor.","date":"2018","source":"Shock (Augusta, Ga.)","url":"https://pubmed.ncbi.nlm.nih.gov/29668526","citation_count":41,"is_preprint":false},{"pmid":"22937039","id":"PMC_22937039","title":"Fc gamma receptor CD64 modulates the inhibitory activity of infliximab.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22937039","citation_count":41,"is_preprint":false},{"pmid":"39617174","id":"PMC_39617174","title":"An engineered α1β1 integrin-mediated FcγRI signaling component to control enhanced CAR macrophage activation and phagocytosis.","date":"2024","source":"Journal of controlled release : official journal of the Controlled Release Society","url":"https://pubmed.ncbi.nlm.nih.gov/39617174","citation_count":40,"is_preprint":false},{"pmid":"32031762","id":"PMC_32031762","title":"Role of the interferons in CD64 and CD169 expressions in whole blood: Relevance in the balance between viral- or bacterial-oriented immune responses.","date":"2020","source":"Immunity, inflammation and disease","url":"https://pubmed.ncbi.nlm.nih.gov/32031762","citation_count":40,"is_preprint":false},{"pmid":"21124939","id":"PMC_21124939","title":"Fcγ receptor I alpha chain (CD64) expression in macrophages is critical for the onset of meningitis by Escherichia coli K1.","date":"2010","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/21124939","citation_count":36,"is_preprint":false},{"pmid":"26497521","id":"PMC_26497521","title":"Structural mechanism of high affinity FcγRI recognition of immunoglobulin G.","date":"2015","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/26497521","citation_count":36,"is_preprint":false},{"pmid":"11092616","id":"PMC_11092616","title":"Production of macrophage-activated killer cells for targeting of glioblastoma cells with bispecific antibody to FcgammaRI and the epidermal growth factor receptor.","date":"2000","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/11092616","citation_count":36,"is_preprint":false},{"pmid":"36593395","id":"PMC_36593395","title":"Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression.","date":"2023","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/36593395","citation_count":34,"is_preprint":false},{"pmid":"21874613","id":"PMC_21874613","title":"Evaluation of adhesion molecules CD64, CD11b and CD62L in neutrophils and monocytes of peripheral blood for early diagnosis of neonatal infection.","date":"2011","source":"World journal of pediatrics : WJP","url":"https://pubmed.ncbi.nlm.nih.gov/21874613","citation_count":34,"is_preprint":false},{"pmid":"29920250","id":"PMC_29920250","title":"FcγRI (CD64) contributes to the severity of immune inflammation through regulating NF-κB/NLRP3 inflammasome pathway.","date":"2018","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29920250","citation_count":33,"is_preprint":false},{"pmid":"15868620","id":"PMC_15868620","title":"Neutrophil CD64 expression in Behçet's disease.","date":"2005","source":"The Journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/15868620","citation_count":33,"is_preprint":false},{"pmid":"8662746","id":"PMC_8662746","title":"A role for Shc, Grb2, and Raf-1 in FcgammaRI signal relay.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8662746","citation_count":33,"is_preprint":false},{"pmid":"20109752","id":"PMC_20109752","title":"Targeting allergen to FcgammaRI reveals a novel T(H)2 regulatory pathway linked to thymic stromal lymphopoietin receptor.","date":"2010","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20109752","citation_count":31,"is_preprint":false},{"pmid":"28898742","id":"PMC_28898742","title":"Neutrophil CD64, C-reactive protein, and procalcitonin in the identification of sepsis in the ICU - Post-test probabilities.","date":"2017","source":"Journal of critical care","url":"https://pubmed.ncbi.nlm.nih.gov/28898742","citation_count":31,"is_preprint":false},{"pmid":"30042128","id":"PMC_30042128","title":"Mechanisms of inside-out signaling of the high-affinity IgG receptor FcγRI.","date":"2018","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/30042128","citation_count":31,"is_preprint":false},{"pmid":"32076472","id":"PMC_32076472","title":"Effect of neutrophil CD64 for diagnosing sepsis in emergency department.","date":"2020","source":"World journal of emergency medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32076472","citation_count":29,"is_preprint":false},{"pmid":"30262053","id":"PMC_30262053","title":"Combined CD25, CD64, and CD69 biomarker panel for flow cytometry diagnosis of sepsis.","date":"2018","source":"Talanta","url":"https://pubmed.ncbi.nlm.nih.gov/30262053","citation_count":29,"is_preprint":false},{"pmid":"27565453","id":"PMC_27565453","title":"Neutrophil CD64 expression as a longitudinal biomarker for severe disease and acute infection in critically ill patients.","date":"2016","source":"International journal of laboratory hematology","url":"https://pubmed.ncbi.nlm.nih.gov/27565453","citation_count":28,"is_preprint":false},{"pmid":"29144515","id":"PMC_29144515","title":"Detection of sepsis in patient blood samples using CD64 expression in a microfluidic cell separation device.","date":"2017","source":"The Analyst","url":"https://pubmed.ncbi.nlm.nih.gov/29144515","citation_count":28,"is_preprint":false},{"pmid":"33897897","id":"PMC_33897897","title":"Genetic engineering cellular vesicles expressing CD64 as checkpoint antibody carrier for cancer immunotherapy.","date":"2021","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/33897897","citation_count":28,"is_preprint":false},{"pmid":"27268050","id":"PMC_27268050","title":"Meta-analysis of diagnostic accuracy of neutrophil CD64 for neonatal sepsis.","date":"2016","source":"Italian journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/27268050","citation_count":27,"is_preprint":false},{"pmid":"10514529","id":"PMC_10514529","title":"The cytoplasmic domain of human FcgammaRIa alters the functional properties of the FcgammaRI.gamma-chain receptor complex.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10514529","citation_count":26,"is_preprint":false},{"pmid":"18097060","id":"PMC_18097060","title":"Targeting immune complex-mediated hypersensitivity with recombinant soluble human FcgammaRIA (CD64A).","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18097060","citation_count":26,"is_preprint":false},{"pmid":"19454724","id":"PMC_19454724","title":"Recombinant soluble human FcgammaR1A (CD64A) reduces inflammation in murine collagen-induced arthritis.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19454724","citation_count":26,"is_preprint":false},{"pmid":"27725776","id":"PMC_27725776","title":"Leukocyte immunoglobulin-like receptor B4 regulates key signalling molecules involved in FcγRI-mediated clathrin-dependent endocytosis and phagocytosis.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27725776","citation_count":25,"is_preprint":false},{"pmid":"31094395","id":"PMC_31094395","title":"Smartphone-imaged microfluidic biochip for measuring CD64 expression from whole blood.","date":"2019","source":"The Analyst","url":"https://pubmed.ncbi.nlm.nih.gov/31094395","citation_count":25,"is_preprint":false},{"pmid":"9716598","id":"PMC_9716598","title":"SLP-76-Cbl-Grb2-Shc interactions in FcgammaRI signaling.","date":"1998","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9716598","citation_count":25,"is_preprint":false},{"pmid":"30446886","id":"PMC_30446886","title":"Utility of neutrophil CD64 and serum TREM-1 in distinguishing bacterial infection from disease flare in SLE and ANCA-associated vasculitis.","date":"2018","source":"Clinical rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/30446886","citation_count":25,"is_preprint":false},{"pmid":"17709506","id":"PMC_17709506","title":"FcR gamma-chain dependent signaling in immature neutrophils is mediated by FcalphaRI, but not by FcgammaRI.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17709506","citation_count":24,"is_preprint":false},{"pmid":"10519993","id":"PMC_10519993","title":"Role of FcgammaRI (CD64) in erythrocyte elimination and its up-regulation in thalassaemia.","date":"1999","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/10519993","citation_count":23,"is_preprint":false},{"pmid":"15161926","id":"PMC_15161926","title":"Modulation of FcgammaRI (CD64) ligand binding by blocking peptides of periplakin.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15161926","citation_count":23,"is_preprint":false},{"pmid":"30190171","id":"PMC_30190171","title":"Lentivirus-mediated knockdown of FcγRI (CD64) attenuated lupus nephritis via inhibition of NF-κB regulating NLRP3 inflammasome activation in MRL/lpr mice.","date":"2018","source":"Journal of pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30190171","citation_count":23,"is_preprint":false},{"pmid":"36284837","id":"PMC_36284837","title":"Targeting the high affinity receptor, FcγRI, in autoimmune disease, neuropathy, and cancer.","date":"2022","source":"Immunotherapy advances","url":"https://pubmed.ncbi.nlm.nih.gov/36284837","citation_count":22,"is_preprint":false},{"pmid":"19721054","id":"PMC_19721054","title":"Neutrophil CD64 expression in the diagnosis of local musculoskeletal infection and the impact of antibiotics.","date":"2009","source":"The Journal of bone and joint surgery. British volume","url":"https://pubmed.ncbi.nlm.nih.gov/19721054","citation_count":22,"is_preprint":false},{"pmid":"33431684","id":"PMC_33431684","title":"The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33431684","citation_count":21,"is_preprint":false},{"pmid":"34377464","id":"PMC_34377464","title":"High expression of neutrophil and monocyte CD64 with simultaneous lack of upregulation of adhesion receptors CD11b, CD162, CD15, CD65 on neutrophils in severe COVID-19.","date":"2021","source":"Therapeutic advances in infectious disease","url":"https://pubmed.ncbi.nlm.nih.gov/34377464","citation_count":21,"is_preprint":false},{"pmid":"17227821","id":"PMC_17227821","title":"Immune complexes suppress IFN-gamma signaling by activation of the FcgammaRI pathway.","date":"2007","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/17227821","citation_count":21,"is_preprint":false},{"pmid":"25180450","id":"PMC_25180450","title":"Neutrophil CD64 expression as an important diagnostic marker of infection and sepsis in hospital patients.","date":"2014","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/25180450","citation_count":21,"is_preprint":false},{"pmid":"40145093","id":"PMC_40145093","title":"Guselkumab binding to CD64+ IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signaling.","date":"2025","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/40145093","citation_count":20,"is_preprint":false},{"pmid":"30029898","id":"PMC_30029898","title":"Neutrophil CD64, TLR2 and TLR4 expression increases but phagocytic potential decreases during tuberculosis.","date":"2018","source":"Tuberculosis (Edinburgh, Scotland)","url":"https://pubmed.ncbi.nlm.nih.gov/30029898","citation_count":20,"is_preprint":false},{"pmid":"23757034","id":"PMC_23757034","title":"Are neutrophil CD64 expression and interleukin-6 early useful markers for diagnosis of acute appendicitis?","date":"2013","source":"European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie","url":"https://pubmed.ncbi.nlm.nih.gov/23757034","citation_count":20,"is_preprint":false},{"pmid":"17827066","id":"PMC_17827066","title":"Hyperexpression of FcgammaRI and Toll-like receptor 4 in the intestinal mast cells of Crohn's disease patients.","date":"2007","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/17827066","citation_count":20,"is_preprint":false},{"pmid":"12200451","id":"PMC_12200451","title":"The CY domain of the Fcgamma RIa alpha-chain (CD64) alters gamma-chain tyrosine-based signaling and phagocytosis.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12200451","citation_count":20,"is_preprint":false},{"pmid":"23867450","id":"PMC_23867450","title":"Diagnostic accuracy of neutrophil CD64 expression in neonatal infection: a meta-analysis.","date":"2013","source":"The Journal of international medical research","url":"https://pubmed.ncbi.nlm.nih.gov/23867450","citation_count":19,"is_preprint":false},{"pmid":"25804673","id":"PMC_25804673","title":"Monocyte CD64 expression as a novel biomarker for the disease activity of systemic lupus erythematosus.","date":"2015","source":"Lupus","url":"https://pubmed.ncbi.nlm.nih.gov/25804673","citation_count":19,"is_preprint":false},{"pmid":"36727833","id":"PMC_36727833","title":"Neuronal C-Reactive Protein/FcγRI Positive Feedback Proinflammatory Signaling Contributes to Nerve Injury Induced Neuropathic Pain.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/36727833","citation_count":18,"is_preprint":false},{"pmid":"30273630","id":"PMC_30273630","title":"The alternatively spliced porcine FcγRI regulated PRRSV-ADE infection and proinflammatory cytokine production.","date":"2018","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30273630","citation_count":18,"is_preprint":false},{"pmid":"10405359","id":"PMC_10405359","title":"Influence of the human high-affinity IgG receptor FcgammaRI (CD64) on residual infectivity of neutralized dengue virus.","date":"1999","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/10405359","citation_count":18,"is_preprint":false},{"pmid":"31085013","id":"PMC_31085013","title":"Diagnostic value of neutrophil CD64 combined with CRP for neonatal sepsis: A meta-analysis.","date":"2019","source":"The American journal of emergency medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31085013","citation_count":18,"is_preprint":false},{"pmid":"29540108","id":"PMC_29540108","title":"Neutrophil CD64 expression, procalcitonin and presepsin are useful to differentiate infections from flares in SLE patients with SIRS.","date":"2018","source":"Lupus","url":"https://pubmed.ncbi.nlm.nih.gov/29540108","citation_count":18,"is_preprint":false},{"pmid":"32890312","id":"PMC_32890312","title":"Evaluating the Timeliness and Specificity of CD69, CD64, and CD25 as Biomarkers of Sepsis in Mice.","date":"2021","source":"Shock (Augusta, Ga.)","url":"https://pubmed.ncbi.nlm.nih.gov/32890312","citation_count":16,"is_preprint":false},{"pmid":"38056893","id":"PMC_38056893","title":"iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting.","date":"2023","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/38056893","citation_count":16,"is_preprint":false},{"pmid":"29872553","id":"PMC_29872553","title":"Obinutuzumab activates FcγRI more potently than other anti-CD20 antibodies in chronic lymphocytic leukemia (CLL).","date":"2018","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/29872553","citation_count":16,"is_preprint":false},{"pmid":"26497520","id":"PMC_26497520","title":"The high-affinity receptor for IgG, FcγRI, of humans and non-human primates.","date":"2015","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/26497520","citation_count":15,"is_preprint":false},{"pmid":"18279703","id":"PMC_18279703","title":"Expression of CD64, CD206, and RAGE in adherent cells of diabetic patients infected with Mycobacterium tuberculosis.","date":"2008","source":"Archives of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/18279703","citation_count":15,"is_preprint":false},{"pmid":"29352854","id":"PMC_29352854","title":"Fc gamma receptor binding profile of anti-citrullinated protein antibodies in immune complexes suggests a role for FcγRI in the pathogenesis of synovial inflammation.","date":"2018","source":"Clinical and experimental rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/29352854","citation_count":15,"is_preprint":false},{"pmid":"19689341","id":"PMC_19689341","title":"Fcgamma receptor 1 (CD64), a target beyond cancer.","date":"2009","source":"Current pharmaceutical design","url":"https://pubmed.ncbi.nlm.nih.gov/19689341","citation_count":15,"is_preprint":false},{"pmid":"36716100","id":"PMC_36716100","title":"Development of an Aptamer-Based Molecular Tool for Specifically Targeting Microglia via the CD64 Protein.","date":"2023","source":"Analytical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36716100","citation_count":15,"is_preprint":false},{"pmid":"15192052","id":"PMC_15192052","title":"CpG oligodeoxynucleotides enhance FcgammaRI-mediated cross presentation by dendritic cells.","date":"2004","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15192052","citation_count":15,"is_preprint":false},{"pmid":"11420747","id":"PMC_11420747","title":"Tumor cells express FcgammaRI which contributes to tumor cell growth and a metastatic phenotype.","date":"2001","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11420747","citation_count":15,"is_preprint":false},{"pmid":"15136586","id":"PMC_15136586","title":"The monocyte Fcgamma receptors FcgammaRI/gamma and FcgammaRIIA differ in their interaction with Syk and with Src-related tyrosine kinases.","date":"2004","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/15136586","citation_count":15,"is_preprint":false},{"pmid":"9737671","id":"PMC_9737671","title":"FcgammaRIa-gamma-chain complexes trigger antibody-dependent cell-mediated cytotoxicity (ADCC) in CD5+ B cell/macrophage IIA1.6 cells.","date":"1998","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9737671","citation_count":14,"is_preprint":false},{"pmid":"39187291","id":"PMC_39187291","title":"CD64+ fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8+ T cells.","date":"2024","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/39187291","citation_count":14,"is_preprint":false},{"pmid":"8663283","id":"PMC_8663283","title":"Extracellular mutations of non-obese diabetic mouse FcgammaRI modify surface expression and ligand binding.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8663283","citation_count":14,"is_preprint":false},{"pmid":"38332201","id":"PMC_38332201","title":"Crosstalk between CD64+MHCII+ macrophages and CD4+ T cells drives joint pathology during chikungunya.","date":"2024","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38332201","citation_count":14,"is_preprint":false},{"pmid":"35371020","id":"PMC_35371020","title":"Novel Human FCGR1A Variants Affect CD64 Functions and Are Risk Factors for Sarcoidosis.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35371020","citation_count":13,"is_preprint":false},{"pmid":"30915651","id":"PMC_30915651","title":"Accuracy of neutrophil CD64 expression in diagnosing infection in patients with autoimmune diseases: a meta-analysis.","date":"2019","source":"Clinical rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/30915651","citation_count":13,"is_preprint":false},{"pmid":"31510805","id":"PMC_31510805","title":"iNK-CD64/16A cells: a promising approach for ADCC?","date":"2019","source":"Expert opinion on biological therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31510805","citation_count":13,"is_preprint":false},{"pmid":"27564103","id":"PMC_27564103","title":"CD64-directed microtubule associated protein tau kills leukemic blasts ex vivo.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27564103","citation_count":13,"is_preprint":false},{"pmid":"30712229","id":"PMC_30712229","title":"Accuracy of CD64 expression on neutrophils and monocytes in bacterial infection diagnosis at pediatric intensive care admission.","date":"2019","source":"European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/30712229","citation_count":13,"is_preprint":false},{"pmid":"31787334","id":"PMC_31787334","title":"CD64-targeted HO-1 RNA interference enhances chemosensitivity in orthotopic model of acute myeloid leukemia and patient-derived bone marrow cells.","date":"2019","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/31787334","citation_count":13,"is_preprint":false},{"pmid":"26743033","id":"PMC_26743033","title":"Fully human MAP-fusion protein selectively targets and eliminates proliferating CD64(+) M1 macrophages.","date":"2016","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/26743033","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51256,"output_tokens":8298,"usd":0.139119},"stage2":{"model":"claude-opus-4-6","input_tokens":12780,"output_tokens":3751,"usd":0.236512},"total_usd":0.375631,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"The FcγRIa (CD64) ligand-binding α-chain cytoplasmic tail contains autonomous targeting information directing receptor-antigen complexes to MHC class II-containing late endosomes for antigen presentation, independently of the FcR γ-chain ITAM. Radical deletion of the cytoplasmic tail diverted receptor-ligand complexes to the recycling pathway and decreased antigen presentation, demonstrating γ-chain-independent MHC class II presentation by FcγRIa.\",\n      \"method\": \"Cell transfection with cytoplasmic-tail deletion mutants, immunoelectron microscopy tracking of receptor-antigen complexes, MHC class II antigen presentation assay in IIA1.6 cell model\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis and direct ultrastructural localization, multiple orthogonal methods in one study\",\n      \"pmids\": [\"10397749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The FcγRIa extracellular domain is sufficient for internalization of infectious dengue virus immune complexes; deletion of the FcγRIa cytoplasmic domain had no effect on receptor-mediated immune complex infectivity, demonstrating that classical ITAM-dependent signaling is not required for this internalization event.\",\n      \"method\": \"COS cell transfection with native and cytoplasmic-domain-truncated FcγRIa (±γ-chain), plaque assay for dengue virus replication\",\n      \"journal\": \"Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with truncation mutants, single study\",\n      \"pmids\": [\"10405359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The cytoplasmic domain (CY) of the FcγRIa α-chain directly alters the functional properties of the FcγRIa/γ-chain receptor complex: deletion of CY slows phagocytosis and endocytosis kinetics, converts calcium-independent phagocytosis to calcium-dependent, and abrogates IL-6 (but not IL-1β) secretion without affecting receptor surface expression.\",\n      \"method\": \"Stable transfection of full-length vs. CY-deletion mutants of human FcγRIa in mouse macrophage P388D1 cells; phagocytosis, endocytosis kinetics, calcium flux, cytokine secretion assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis, multiple orthogonal functional readouts\",\n      \"pmids\": [\"10514529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The second and third extracellular domains of FcγRI together confer unique high-affinity monomeric IgG2a binding; domain 1 plays a supporting role in conformational stability. Chimeric receptors replacing domains 1+2 with FcγRII equivalents abolished high-affinity binding; restoring domain 2 of FcγRI (keeping domain 1 of FcγRII) reconstituted high-affinity IgG2a binding.\",\n      \"method\": \"Generation of chimeric FcγRI/FcγRII receptors by domain exchange, transfection and IgG binding assays\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — domain-swap mutagenesis reconstitution, clear structure-function mapping\",\n      \"pmids\": [\"9881694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"FcγRI cross-linking in IFN-γ-differentiated U937 cells induces tyrosine phosphorylation of Raf-1 (10-fold increase, peaking 1-2 min post-stimulation), recruits Shc-Grb2 complex formation, and precedes activation of the respiratory burst; this signaling is unique to FcγRI and not triggered by FcγRII, FcγRIII, PMA, fMLP, or other stimuli.\",\n      \"method\": \"FcγRI cross-linking in U937IF cells, immunoprecipitation and western blotting for Raf-1 phosphorylation, Shc-Grb2 co-immunoprecipitation, respiratory burst assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with kinetics and receptor specificity controls, multiple orthogonal methods\",\n      \"pmids\": [\"8662746\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"FcγRI stimulation induces tyrosine phosphorylation of SLP-76, Cbl, and Shc, and promotes formation of a multimolecular SLP-76–Cbl–Shc–Grb2 complex; a phosphorylation-dependent SLP-76–Shc interaction is induced ≥10-fold by FcγRI aggregation, identifying SLP-76 and Cbl as components of FcγRI signal relay.\",\n      \"method\": \"FcγRI cross-linking in U937IF cells, co-immunoprecipitation, phospho-tyrosine western blotting\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with quantitative phosphorylation analysis, single lab\",\n      \"pmids\": [\"9716598\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Serine phosphorylation of the FcγRIa α-chain cytoplasmic domain is a critical regulatory mechanism: truncation or serine-to-alanine mutation of the cytoplasmic domain abolished okadaic-acid-sensitive inhibition of phagocytosis and the early tyrosine phosphorylation cascade, demonstrating that α-chain serine phosphorylation regulates γ-chain ITAM-dependent signaling.\",\n      \"method\": \"Mutagenesis of cytoplasmic serine residues in human FcγRIa variants expressed in P388D1 macrophages; okadaic acid inhibition experiments; phagocytosis and tyrosine phosphorylation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with pharmacological validation and multiple functional readouts\",\n      \"pmids\": [\"12200451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"FcγRI−/− mice display impaired endocytosis of monomeric IgG, reduced kinetics of immune complex phagocytosis, defective macrophage ADCC, and impaired immune complex-dependent antigen presentation to primed T cells; FcγRI also controls antibody response magnitude and can function partially without the FcR γ-chain.\",\n      \"method\": \"FcγRI knockout mouse model, phagocytosis assays, ADCC assays, antigen presentation assays, serum antibody measurements\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple defined cellular phenotypes, replicated alongside companion paper\",\n      \"pmids\": [\"11911823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"FcγRI contributes substantially to IgG2a immune complex-induced phagocytosis, cytokine release, cellular cytotoxicity, and antigen presentation in vivo; FcγRI−/− mice show impaired hypersensitivity responses, strongly reduced cartilage destruction in arthritis, and impaired protection from bacterial infection.\",\n      \"method\": \"FcγR-knockout mouse panel; hypersensitivity models, immune arthritis model, bacterial infection protection assay\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple KO models with defined in vivo phenotypes, strong evidence across multiple assays\",\n      \"pmids\": [\"11911824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Periplakin C-terminus selectively interacts with the FcγRI α-chain cytoplasmic domain and enhances FcγRI capacity to bind, internalize, and present antigens on MHC class II. TAT peptides disrupting this endogenous FcγRI–periplakin interaction modulate FcγRI ligand binding, establishing periplakin as a novel cytosolic regulator of FcγRI function.\",\n      \"method\": \"Truncation and alanine-substitution mutagenesis of FcγRI and periplakin; TAT peptide inhibition; erythrocyte-antibody rosetting assay; antigen presentation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis reconstitution plus peptide inhibitor functional validation\",\n      \"pmids\": [\"15161926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"IFN-γ-induced FcγRI (CD64) expression on human mast cells enables their activation by aggregated IgG1 (but not IgG2/3/4), leading to degranulation (β-hexosaminidase release), PGD2, LTC4, IL-3, IL-13, GM-CSF, and TNFα production; C3a produces additive degranulation. Blocking FcγRI with F(ab')2 reduces IgG1-mediated degranulation by 38%.\",\n      \"method\": \"IFN-γ priming of human mast cells, aggregated IgG stimulation, β-hexosaminidase release assay, receptor-blocking antibody experiments, eicosanoid and cytokine measurements\",\n      \"journal\": \"Clinical immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — receptor-blocking plus multiple functional readouts, single lab\",\n      \"pmids\": [\"15003814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"FcγRIa ITAM signaling (via γ-chain) is required for both phagocytosis and dengue virus immune complex infectivity enhancement; abrogating FcγRIa signaling competency (by expression without γ-chain or with ITAM tyrosine mutant γ-chain) impairs both phagocytosis and dengue IC infectivity, whereas FcγRIIa ITAM abrogation impairs phagocytosis but not infectivity—demonstrating fundamental mechanistic differences between the two receptors.\",\n      \"method\": \"Site-directed mutagenesis of ITAM tyrosine residues; COS-7 transfection with native/signaling-incompetent receptor variants; plaque assay; flow cytometry for dengue replication\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis reconstitution with direct functional comparison, multiple receptor variants\",\n      \"pmids\": [\"17005690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In immature neutrophils, FcγRI (CD64) has a weaker association with the FcR γ-chain than FcαRI does, resulting in absent FcγRI-mediated γ-chain-dependent functions (ADCC, respiratory burst, calcium mobilization, MAPK phosphorylation) while γ-chain-independent internalization proceeds normally via both receptors.\",\n      \"method\": \"Co-immunoprecipitation of FcγRI and FcαRI with FcR γ-chain in mature vs. immature neutrophils; calcium mobilization, MAPK phosphorylation, ADCC, respiratory burst assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP plus multiple functional readouts, single lab\",\n      \"pmids\": [\"17709506\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Immune complexes inhibit IFN-γ–induced STAT1 phosphorylation through FcγRI: IC-mediated inhibition is reduced in FcR common γ-chain knockout cells, and requires the phosphatase SHP-1 (as shown by motheaten SHP-1 KO cells), suppressing STAT1 without blocking STAT1 binding to the IFN-γ receptor.\",\n      \"method\": \"Pull-down assays for STAT1 phosphorylation; real-time RT-PCR for IFN-inducible genes; experiments with FcR γ-chain KO and SHP-1 KO (motheaten) mouse cells\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with KO cells, pull-down, multiple readouts; single lab\",\n      \"pmids\": [\"17227821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"LILRB4 (LILRB4) potently inhibits FcγRI (CD64)-mediated TNFα production by dephosphorylating Lck, Syk, LAT, Erk, and c-Cbl (but not α-actinin-4) upon co-ligation with CD64 on monocytes; LILRB4 aggregates to sites of FcγRI activation, and its inhibitory effect is reversed by broad phosphatase inhibitor (pervanadate) but not by the SHP-1-specific inhibitor sodium stibogluconate, implicating phosphatases other than SHP-1.\",\n      \"method\": \"Co-ligation of LILRB4 and CD64 on THP-1 cells; TNFα ELISA; western blotting for phosphorylated Lck, Syk, LAT, Erk, c-Cbl, α-actinin-4; pharmacological phosphatase inhibition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple phospho-protein targets identified with pharmacological rescue, multiple orthogonal methods\",\n      \"pmids\": [\"19833736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"FcγRI α-chain cytoplasmic tail interaction with the outer membrane protein A (OmpA) of E. coli K1 enables bacterial entry into macrophages independent of IgG opsonization. OmpA binding to FcγRIa prevents γ-chain recruitment and produces a distinct tyrosine phosphorylation pattern from IgG2a-induced phosphorylation. FcγRIa−/− mice are resistant to E. coli K1 meningitis due to accelerated bacterial clearance and increased CR3 expression.\",\n      \"method\": \"COS-1 overexpression of full-length vs. C-terminal truncated FcγRIa; FcγRIa−/− mouse bacterial infection model; adoptive macrophage transfer; co-immunoprecipitation; tyrosine phosphorylation analysis\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with adoptive transfer rescue, cell transfection mutagenesis, co-IP, multiple readouts\",\n      \"pmids\": [\"21124939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Targeting allergen to FcγRI on dendritic cells upregulates TSLP receptor via a signaling pathway requiring FcγRI-associated src-related tyrosine kinases, Syk, and PI3K; inhibition of TSLP receptor upregulation blocks TSLP-mediated Th2 responses, linking FcγRI signaling to a novel Th2 regulatory pathway.\",\n      \"method\": \"Monocyte-derived DC priming with FcγRI-targeting allergen fusion protein (H22-Fel d 1); inhibitors of Fc receptor signaling (src kinases, Syk, PI3K); TSLP receptor flow cytometry; T cell cytokine analysis\",\n      \"journal\": \"The Journal of allergy and clinical immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological pathway dissection with functional T cell readout, single lab\",\n      \"pmids\": [\"20109752\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"LILRB4 co-ligation with FcγRI causes Tyr dephosphorylation of key clathrin-mediated endocytosis pathway components—including the FcR common γ-chain, Syk, clathrin, Cbl, HRS, TRIM21, and HSP70—and suppresses FcR-dependent uptake of antibody-opsonized bacterial particles, indicating LILRB4 regulates FcγRI-dependent phagocytosis/endocytosis via Tyr dephosphorylation.\",\n      \"method\": \"Antibody ligation of FcγRI ± LILRB4 on THP-1 cells; anti-pTyr immunoprecipitation; mass spectrometry peptide sequencing; Ingenuity Pathway Analysis; bacterial phagocytosis assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mass spectrometry phosphoproteomics with functional phagocytosis validation, multiple pathway components identified\",\n      \"pmids\": [\"27725776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Cytokine-induced 'inside-out' signaling enhances FcγRI clustering (nanoscale reorganization) dependent on an intact actin cytoskeleton and on PP1 phosphatase activity (PP1 inhibition reduces inside-out signaling without affecting FcγRI phosphorylation itself); IL-3, TNFα, and IFNγ all stimulate this clustering and enhance ADCC of CD20+ tumor cells by neutrophils.\",\n      \"method\": \"Super-resolution microscopy (STORM) of FcγRI clustering; pharmacological inhibition of PP1; actin cytoskeleton disruption; ADCC assay with neutrophils\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — super-resolution imaging with pharmacological mechanism dissection and functional ADCC validation\",\n      \"pmids\": [\"30042128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"FcγRI/CD64 promotes immune inflammation via activation of NF-κB signaling, which in turn drives NLRP3 inflammasome formation and IL-1β/IL-18 release; FcγRI expression in Ba/F3 cells induces this pathway, and silencing FcγRI in THP-1 macrophages reverses it.\",\n      \"method\": \"FcγRI overexpression in Ba/F3 cells; FcγRI siRNA knockdown in THP-1 macrophages; NF-κB inhibitor (PDTC); western blotting for NLRP3 components; ELISA for IL-1β and IL-18\",\n      \"journal\": \"Life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain- and loss-of-function with pharmacological epistasis, single lab\",\n      \"pmids\": [\"29920250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"FcγRI is expressed in a subpopulation of joint sensory neurons; IgG immune complex crosslinking of FcγRI directly activates the somata and peripheral terminals of these neurons to evoke acute joint hypernociception without joint inflammation. Conditional deletion of Fcgr1 in sensory neurons attenuated arthritis pain and joint sensory neuron hyperactivity without altering joint inflammation.\",\n      \"method\": \"Global and sensory-neuron-specific Fcgr1 conditional knockout mice; ex vivo electrophysiology of joint sensory neurons; behavioral pain assays; inflammatory arthritis models; IgG-IC injection\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific KO with electrophysiology and behavioral readouts, multiple arthritis models\",\n      \"pmids\": [\"31211699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Exogenous antigen targeted to FcγRI (CD64) on myeloid cells (THP-1) is internalized and processed for presentation on MHC class I molecules, enabling CTL-mediated lysis; blocking either FcγRI or MHC class I abrogates lysis, demonstrating FcγRI-mediated cross-presentation (MHC I) pathway.\",\n      \"method\": \"FcγRI-targeted PSA fusion protein (FPH22.PSA) on THP-1 cells; CTL cytotoxicity assay; receptor-blocking with anti-FcγRI and anti-MHC class I antibodies\",\n      \"journal\": \"Journal of immunological methods\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — receptor blocking with defined cytolytic readout, single lab\",\n      \"pmids\": [\"11223078\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"FcγRI-mediated cross-presentation via MHC class I is enhanced by CpG ODN co-stimulation; hFcγRI transgenic DC show increased MHC class I presentation of FcγRI-targeted antigens (ovalbumin via CD64 mAb fusion) upon CpG addition compared to non-transgenic DC.\",\n      \"method\": \"hFcγRI transgenic and non-transgenic DC; antigen-CD64 mAb fusion protein targeting; CpG ODN co-stimulation; MHC class I presentation assay with OVA-specific CD8+ T cells\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — transgenic model with selective receptor targeting, single lab\",\n      \"pmids\": [\"15192052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"FcγRI (CD64) and FcγRIIB on dendritic cells and macrophages both mediate accelerated antigen presentation (T cell proliferation, IgG production) via immune complex uptake; DC lacking FcγRIIB show reduced IC-uptake and decreased T-cell stimulation, while DC expressing only FcγRIIB (FcR γ-chain deficient) outperform FcγR-null DC, revealing positive regulation of antigen presentation by FcγRIIB alongside FcγRI/III.\",\n      \"method\": \"FcγRIIB KO and FcR γ-chain KO bone marrow-derived DCs; antigen IC uptake assay; T cell proliferation assay; adoptive DC transfer; serum IgG measurement\",\n      \"journal\": \"Cellular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple KO models, epistasis-style comparison, single lab\",\n      \"pmids\": [\"14643301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"FcγRIa-γ-chain complexes require an intact γ-chain ITAM to trigger phagocytosis of S. aureus and ADCC of erythrocytes in IIA1.6 cells; both γ-chain ITAM and FcγRIIa ITAM can direct these functions when coupled to the FcγRIa extracellular domain.\",\n      \"method\": \"FcγRIa-γ-chain complex reconstitution in IIA1.6 cells; ITAM mutant γ-chain; phagocytosis of S. aureus; ADCC assay with erythrocytes\",\n      \"journal\": \"Clinical and experimental immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — receptor reconstitution with ITAM requirement demonstrated, single lab\",\n      \"pmids\": [\"9737671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"FcγRIIA interacts more readily with Syk than does FcγRI/γ-chain chimera, contributing to greater phagocytic efficiency of FcγRIIA; individual Src-related tyrosine kinases (Hck, Lyn) differentially influence phagocytosis efficiency and Syk interaction for FcγRI/γ versus FcγRIIA.\",\n      \"method\": \"Transfection of FcγRIIA and FcγRI-gamma-gamma chimera in COS-1 cells; co-immunoprecipitation with Syk, Hck, Lyn; phagocytosis assay\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with functional phagocytosis comparison, single lab\",\n      \"pmids\": [\"15136586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Conditional knockout of Fcgr1 in rat DRG neurons significantly alleviates neuropathic pain after sciatic nerve injury; CRP (elevated in DRG after nerve injury) activates neuronal FcγRI-related signals to evoke pain, and microinjection of naive IgG into DRG suppresses FcγRI activation and alleviates pain, establishing a CRP/FcγRI positive-feedback proinflammatory signaling loop in sensory neurons.\",\n      \"method\": \"Fcgr1 conditional knockout in rat DRG neurons; CRP microinjection into DRG; naive IgG microinjection; behavioral pain assays; signaling analysis in primary neurons\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — neuron-specific CKO with behavioral and signaling readouts, single lab\",\n      \"pmids\": [\"36727833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Crystal/structural studies of human FcγRI in complex with IgG-Fc revealed the molecular basis for high-affinity binding, including a potential receptor-glycan interaction as a contributor to affinity differences among FcγRs.\",\n      \"method\": \"Structural determination (crystallography) of FcγRI–IgG-Fc complex with review of structural data\",\n      \"journal\": \"Immunological reviews\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — structural study, review-based coverage without full original data details in abstract\",\n      \"pmids\": [\"26497521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CD64 (FcγRI) modulates the inhibitory activity of infliximab: cells expressing CD64 capture infliximab-TNF complexes via the Fc domain, activating CD64 and producing distinct phospho-tyrosine signals; blocking the Fc portion or using Fab fragments of infliximab improves its TNF-neutralizing efficacy. IFN-γ-induced CD64 upregulation correlates with loss of infliximab efficacy, and CD64 knockdown (siRNA) or downregulation (PMA) restores it.\",\n      \"method\": \"siRNA knockdown of CD64 in THP-1 and PBMCs; Fc-blocking antibody fragments; immunoprecipitation; western blotting for phospho-tyrosine; RT-PCR; immunofluorescence\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — siRNA KD plus pharmacological rescue plus receptor blocking with multiple readouts, single lab\",\n      \"pmids\": [\"22937039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FCGR1A variants affect CD64 functions: promoter SNV rs1848781 alters promoter activity and CD64 expression levels; intronic indel rs587598788 associates with CD64 expression levels; non-synonymous SNV rs1050204 (p.D324N) significantly affects CD64-mediated phagocytosis, degranulation, and pro-inflammatory cytokine production.\",\n      \"method\": \"Promoter reporter assay; genotype-phenotype analysis; phagocytosis assay; degranulation assay; cytokine measurement in cells with different FCGR1A genotypes\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — promoter reporter + functional assays for coding variant, single lab\",\n      \"pmids\": [\"35371020\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Guselkumab (but not risankizumab) binds CD64 on IFNγ-primed monocytes via its Fc domain, enabling simultaneous capture of IL-23 secreted from CD64+ IL-23-producing inflammatory monocytes; this Fc/CD64-dependent mechanism mediates IL-23 internalization into low-pH compartments and enhances potency of IL-23 neutralization in a CD64+ cell co-culture system.\",\n      \"method\": \"Flow cytometry binding assays; live-cell confocal imaging of IL-23 internalization; co-culture of CD64+ THP-1 IL-23-producing cells with IL-23-responsive reporter cells; Fc-mutant antibody comparison\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — imaging with functional co-culture reporter assay and Fc-mutant comparison, single lab\",\n      \"pmids\": [\"40145093\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FcγRI (CD64; FCGR1A) is a three-extracellular-domain high-affinity IgG receptor whose ligand-binding α-chain forms a functional complex with the ITAM-bearing FcR γ-chain; the α-chain cytoplasmic tail undergoes serine phosphorylation that tonically regulates γ-chain ITAM-dependent signaling, phagocytosis kinetics, IL-6 secretion, and intracellular routing of receptor–antigen complexes to MHC class II late endosomes for antigen presentation, while also enabling γ-chain-independent MHC class II and MHC class I cross-presentation. Upon immune complex ligation, FcγRI activates a Syk/Lck/LAT/SLP-76/Shc/Grb2/Raf-1/ERK signaling cascade to drive phagocytosis, cytokine production (including via NF-κB/NLRP3), ADCC, and respiratory burst; cytokine-driven 'inside-out' signaling reorganizes FcγRI into nanoclusters via an actin- and PP1-phosphatase-dependent mechanism to enhance these effector functions. FcγRI is inhibited by LILRB4 co-ligation through broad Tyr dephosphorylation of Syk, Lck, LAT, Erk, and Cbl, and by immune complex-activated SHP-1, which suppresses STAT1 phosphorylation to dampen IFN-γ signaling. Beyond classical myeloid functions, FcγRI is expressed on joint sensory neurons where IgG immune complex crosslinking directly activates nociceptors to drive arthritis pain independently of inflammation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"FCGR1A (CD64/FcγRI) is a high-affinity IgG receptor on myeloid cells that couples immune complex recognition to phagocytosis, antibody-dependent cellular cytotoxicity, antigen presentation, and inflammatory cytokine production. The ligand-binding α-chain, whose second and third extracellular domains confer high-affinity IgG binding [PMID:9881694], associates with the ITAM-bearing FcR γ-chain to activate a Syk/Shc/Grb2/Raf-1/ERK signaling cascade that drives phagocytosis, respiratory burst, and NF-κB/NLRP3-dependent IL-1β release [PMID:8662746, PMID:29920250]; the α-chain cytoplasmic tail independently directs receptor–antigen complexes to MHC class II late endosomes and enables MHC class I cross-presentation, while its serine phosphorylation tonically regulates γ-chain ITAM signaling and phagocytosis kinetics [PMID:10397749, PMID:12200451, PMID:11223078]. Cytokine-driven inside-out signaling reorganizes FcγRI into actin- and PP1-phosphatase-dependent nanoclusters that enhance ADCC [PMID:30042128], whereas inhibitory co-receptors LILRB4 and SHP-1 suppress FcγRI effector functions through broad tyrosine dephosphorylation of downstream signaling components [PMID:19833736, PMID:17227821]. Beyond myeloid cells, FcγRI is expressed on joint sensory neurons where IgG immune complex crosslinking directly activates nociceptors to drive arthritis pain independently of inflammation [PMID:31211699].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Identification of the proximal signaling cascade downstream of FcγRI resolved how this receptor specifically activates the respiratory burst: cross-linking induces Raf-1 tyrosine phosphorylation and Shc–Grb2 complex formation with kinetics preceding functional output, a pathway unique among FcγRs.\",\n      \"evidence\": \"FcγRI cross-linking in IFN-γ-differentiated U937 cells; immunoprecipitation/western blot for Raf-1, Shc, Grb2; respiratory burst assay\",\n      \"pmids\": [\"8662746\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream kinase(s) directly phosphorylating Raf-1 downstream of FcγRI not identified\", \"No direct link to ERK demonstrated in this study\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Domain-swap mutagenesis established that the second and third extracellular domains of FcγRI are the structural determinants of high-affinity monomeric IgG binding, distinguishing it from low-affinity FcγRs and explaining its unique ligand-binding properties.\",\n      \"evidence\": \"Chimeric FcγRI/FcγRII receptors by domain exchange; IgG binding assays in transfected cells\",\n      \"pmids\": [\"9881694\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution contacts not defined until later crystallography\", \"Contribution of receptor glycosylation to affinity not tested\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"The requirement for an intact γ-chain ITAM for FcγRI-mediated phagocytosis and ADCC was formally demonstrated, confirming that the γ-chain is the essential signaling subunit and that SLP-76, Cbl, and Shc participate as downstream adaptors.\",\n      \"evidence\": \"FcγRI reconstitution with wild-type or ITAM-mutant γ-chain in IIA1.6 cells; phagocytosis and ADCC assays; co-IP of SLP-76/Cbl/Shc complex in U937 cells\",\n      \"pmids\": [\"9737671\", \"9716598\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contributions of individual ITAM tyrosines not dissected\", \"No direct kinase–substrate relationships established for SLP-76 or Cbl\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"The α-chain cytoplasmic tail was shown to carry autonomous targeting information directing receptor–antigen complexes to MHC class II late endosomes and to regulate phagocytosis kinetics, calcium dependence, and IL-6 secretion independently of the γ-chain ITAM, establishing a dual-function model for FcγRI signaling.\",\n      \"evidence\": \"Cytoplasmic tail deletion/truncation mutants in IIA1.6 and P388D1 cells; immunoelectron microscopy; antigen presentation, phagocytosis, calcium flux, and cytokine secretion assays\",\n      \"pmids\": [\"10397749\", \"10514529\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific sorting motifs within the cytoplasmic tail not mapped to individual residues\", \"Mechanism of calcium-independent phagocytosis not elucidated\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"FcγRI was demonstrated to mediate cross-presentation on MHC class I, expanding its antigen-presentation repertoire beyond MHC class II and identifying it as a route for CTL priming by myeloid cells.\",\n      \"evidence\": \"FcγRI-targeted PSA fusion protein on THP-1 cells; CTL cytotoxicity assay with receptor-blocking antibodies\",\n      \"pmids\": [\"11223078\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular pathway linking FcγRI internalization to MHC class I loading not defined\", \"Contribution of proteasomal vs. vacuolar processing not tested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"FcγRI knockout mice revealed the in vivo requirement for FcγRI in IgG2a immune complex-mediated phagocytosis, ADCC, antigen presentation, hypersensitivity, cartilage destruction in arthritis, and bacterial defense—establishing that FcγRI is non-redundant with other activating FcγRs in vivo.\",\n      \"evidence\": \"FcγRI−/− mouse models; phagocytosis, ADCC, antigen presentation assays; arthritis and bacterial infection models\",\n      \"pmids\": [\"11911823\", \"11911824\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of monocytes vs. macrophages vs. DCs to each phenotype not resolved\", \"Compensatory changes in other FcγRs not fully assessed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Serine phosphorylation of the α-chain cytoplasmic domain was identified as a tonic regulatory mechanism governing γ-chain ITAM-dependent signaling: serine-to-alanine mutations abolished okadaic acid-sensitive inhibition of phagocytosis and the early tyrosine phosphorylation cascade.\",\n      \"evidence\": \"Serine-to-alanine mutagenesis of FcγRI cytoplasmic domain in P388D1 macrophages; okadaic acid treatment; phagocytosis and phospho-tyrosine assays\",\n      \"pmids\": [\"12200451\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the serine kinase(s) responsible not determined\", \"Specific serine residues mapped only partially\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Periplakin was identified as a cytosolic partner of the FcγRI α-chain that enhances ligand binding, internalization, and MHC class II antigen presentation, revealing a novel cytoskeletal-associated regulatory axis for FcγRI.\",\n      \"evidence\": \"Mutagenesis of FcγRI and periplakin; TAT peptide inhibition of the interaction; rosetting and antigen presentation assays\",\n      \"pmids\": [\"15161926\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of periplakin–FcγRI interaction unknown\", \"Whether periplakin regulates FcγRI on primary cells in vivo not tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Two inhibitory checkpoints on FcγRI signaling were defined: LILRB4 co-ligation broadly dephosphorylates Syk, Lck, LAT, Erk, and Cbl to suppress TNF production, while immune complex-activated SHP-1 suppresses STAT1 phosphorylation to dampen IFN-γ signaling—establishing layered negative regulation of FcγRI effector functions.\",\n      \"evidence\": \"LILRB4/CD64 co-ligation on THP-1 monocytes with phospho-protein western blots and phosphatase inhibitors; STAT1 phosphorylation in FcR γ-chain KO and SHP-1 KO (motheaten) mouse cells\",\n      \"pmids\": [\"19833736\", \"17227821\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the LILRB4-recruited phosphatase(s) other than SHP-1 not established\", \"Whether LILRB4 and SHP-1 pathways converge or operate independently unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"FcγRI was found to serve as a direct entry receptor for E. coli K1 via OmpA binding to the α-chain, independent of IgG opsonization, establishing a pathogen subversion mechanism; FcγRI−/− mice resist E. coli K1 meningitis.\",\n      \"evidence\": \"COS-1 overexpression of full-length vs. C-terminal truncated FcγRI; FcγRI−/− mouse infection model; adoptive macrophage transfer; co-IP and phospho-tyrosine analysis\",\n      \"pmids\": [\"21124939\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise OmpA binding site on FcγRI α-chain not mapped\", \"Whether other bacteria exploit this pathway not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Cytokine-induced inside-out signaling was shown to reorganize FcγRI into nanoclusters via an actin- and PP1-phosphatase-dependent mechanism, enhancing ADCC—revealing that FcγRI effector potency is tuned by receptor spatial organization rather than expression level alone.\",\n      \"evidence\": \"STORM super-resolution imaging of FcγRI clustering on neutrophils; PP1 and actin inhibitors; ADCC assay against CD20+ tumor cells\",\n      \"pmids\": [\"30042128\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"PP1 substrate(s) controlling clustering not identified\", \"Whether nanoclustering affects antigen presentation not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"FcγRI was discovered on joint sensory neurons, where IgG immune complex crosslinking directly activates nociceptors to drive arthritis pain independently of inflammation—extending FcγRI function beyond the immune system to the nervous system.\",\n      \"evidence\": \"Global and sensory-neuron-specific Fcgr1 conditional KO mice; ex vivo electrophysiology; behavioral pain assays in multiple arthritis models\",\n      \"pmids\": [\"31211699\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling pathway in neurons not fully characterized\", \"Whether neuronal FcγRI associates with FcR γ-chain or signals independently unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"The neuronal FcγRI pain axis was extended to neuropathic pain: CRP activates neuronal FcγRI after nerve injury via a positive-feedback proinflammatory loop, and naive IgG competing for FcγRI suppresses this activation and alleviates pain.\",\n      \"evidence\": \"Fcgr1 conditional KO in rat DRG neurons; CRP and naive IgG microinjection into DRG; behavioral pain assays and signaling analysis\",\n      \"pmids\": [\"36727833\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"CRP binding site on FcγRI not mapped\", \"Whether CRP/FcγRI signaling uses ITAM-dependent or independent pathway not resolved\", \"Single lab finding, not independently confirmed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of the serine kinase(s) and PP1 substrates that control α-chain phosphorylation and nanocluster formation, the structural basis for dual γ-chain-dependent and -independent signaling from the same receptor, and the full signaling pathway mediating neuronal FcγRI-driven nociception.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No serine kinase identified for α-chain cytoplasmic tail\", \"Structural model of full-length FcγRI in complex with γ-chain lacking\", \"Neuronal FcγRI signaling pathway incompletely defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [3, 27]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [6, 18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 18, 29]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [0, 9]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [0, 17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [4, 7, 8, 14, 17, 18, 24]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 5, 6, 13, 16, 19]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 17]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 11, 15]}\n    ],\n    \"complexes\": [\n      \"FcγRI α-chain / FcR γ-chain signaling complex\"\n    ],\n    \"partners\": [\n      \"FCER1G\",\n      \"SYK\",\n      \"SHC1\",\n      \"GRB2\",\n      \"SLP76\",\n      \"LILRB4\",\n      \"PPL\",\n      \"CBL\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}